JD, L., PC, L., CT, S., CH, C., YM, W., YC, H., . . . MT, W. (2025). In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma. Dove Medical Press.
Chicago Style (17th ed.) CitationJD, Liang, et al. In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma. Dove Medical Press, 2025.
MLA (9th ed.) CitationJD, Liang, et al. In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma. Dove Medical Press, 2025.
Warning: These citations may not always be 100% accurate.